Although DUX4 expression induces a metastable early embryonic stem cell program and suppresses antigen presentation, contributing to immune evasion, targeting the epigenetic regulators involved in this reprogramming may be possible to reverse the immunosuppressive tumor microenvironment [45]. This evidence concerns the gene DUX4 and neoplasm.